Skyrizi Dosage

Generic name: risankizumab
Drug class: Interleukin inhibitors

Medically reviewed by A Ras MD.

Recommended Adult Dosing

Dosage forms: INJ (auto-injector): 150 mg; INJ (pre-filled syringe): 150 mg per mL; INJ (on-body injector): 360 mg; INJ (vial): various

[formulation clarification]

Info: nonproprietary name = risankizumab-rzaa

[150 mg SC q12wk]

Start: 150 mg SC x1 on wk 0, 4, then q12wk

[150 mg SC q12wk]

Start: 150 mg SC x1 on wk 0, 4, then q12wk; Info: use alone or w/ non-biologic DMARDs

[induction tx]

Dose: 600 mg IV x1 on wk 0, 4, 8

[maintenance tx]

Dose: 360 mg SC q8wk; Start: 4wk after last induction dose

[not defined]

renal impairment: not defined

HD/PD: not defined

[Crohn dz]

cirrhosis: caution advised

[all other indications]

hepatic impairment: not define

SRC: NLM .